- Global Pharma News & Resources

Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities

Zur Rose Group AG / Key word(s): Capital Increase

08-Dec-2021 / 17:42 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.

Please find our press release about a capital increase under the following link:


End of ad hoc announcement
Language: English
Company: Zur Rose Group AG
Walzm├╝hlestrasse 60
8500 Frauenfeld
Phone: +41 52 724 08 14
ISIN: CH0042615283
Listed: SIX Swiss Exchange
EQS News ID: 1255691

End of Announcement EQS News Service

Editor Details

Last Updated: 08-Dec-2021